ATS View
한국어

HLB Pharmaceutical KRX:047920KOSDAQ

HLB제약 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h5
Articles, 7 days10
DART filings, 7 days2
Articles tracked10since Sep 11

In Q2 2026, HLB Pharmaceutical reported revenue of ₩62.3bn, up 32.7% year on year, and an operating loss of ₩31m. HLB Pharmaceutical (HLB제약) appeared in 10 Korean news articles and 2 DART filings over the past seven days. Coverage peaked on Sep 14 with 10 articles. It was most often mentioned alongside NAVER.

HLB Pharmaceutical quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩62.3bn+32.7%−₩31m−₩57m
Q1 2026₩65.7bn+89.5%₩1.0bn₩720m
Q4 2025 derived₩63.4bn+91.7%₩835m₩2.3bn
Q3 2025₩60.6bn+74.3%₩34m−₩161m
Q2 2025₩46.9bn+31.2%−₩1.8bn₩910m
Q1 2025₩34.6bn+3.6%₩2.0bn₩1.6bn
Q4 2024 derived₩33.1bn-1.9%−₩1.2bn₩2.2bn
Q3 2024₩34.8bn+0.4%₩855m₩948m

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

HLB Pharmaceutical top stories 2 weeks, by number of outlets

  1. 1
    HLB제약, 네이버 판매자 최고등급 '플래티넘' 획득
    6 outlets · 6 articlesFirst report Sep 14 08:10 아시아경제NAVER
  2. 2
    HLB제약 유증, 구주주 물량 91% 소화…실권주 92만주 남아
    1 outlets · 1 articlesFirst report Sep 14 14:42 블로터
  3. 3
    HLB제약 유증 91% 방어, 실권주 청약 돌입
    1 outlets · 1 articlesFirst report Sep 14 15:19 경제타임스
  4. 4
    HLB제약, 유상증자 구주주 청약률 91.46%…실권주 91만8973주 일반공모
    1 outlets · 1 articlesFirst report Sep 14 13:21 CBC뉴스
  5. 5
    HLB제약, 네이버 브랜드스토어 '플래티넘' 등급 달성
    1 outlets · 1 articlesFirst report Sep 14 17:05 뉴스1NAVER

Latest HLB Pharmaceutical news Korean headlines